| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0076 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0082 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |